February 9, 2024 01:31 PM EST
FDA+

US and EU reg­u­la­tors be­gin of­fer­ing par­al­lel sci­en­tif­ic ad­vice to gener­ic drug­mak­ers

Zachary Brennan

Senior Editor

The FDA and Eu­ro­pean Med­i­cines Agency col­lab­o­rate of­ten and meet reg­u­lar­ly, but the two drug reg­u­la­tors have now an­nounced that for the first time, they …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times